133 related articles for article (PubMed ID: 38898461)
1. The role of KLRG1: a novel biomarker and new therapeutic target.
Zhang Y; Chen S; Tang X; Peng Y; Jiang T; Zhang X; Li J; Liu Y; Yang Z
Cell Commun Signal; 2024 Jun; 22(1):337. PubMed ID: 38898461
[TBL] [Abstract][Full Text] [Related]
2. Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers.
Tata A; Dodard G; Fugère C; Leget C; Ors M; Rossi B; Vivier E; Brossay L
Oncoimmunology; 2021 Jun; 10(1):1933808. PubMed ID: 34188973
[TBL] [Abstract][Full Text] [Related]
3. Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy.
Yang X; Zheng Y; Han Z; Zhang X
BMC Cancer; 2021 Jun; 21(1):752. PubMed ID: 34187403
[TBL] [Abstract][Full Text] [Related]
4. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G
J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for E-cadherin recognition by killer cell lectin-like receptor G1 (KLRG1).
Nakamura S; Kuroki K; Ohki I; Sasaki K; Kajikawa M; Maruyama T; Ito M; Kameda Y; Ikura M; Yamamoto K; Matsumoto N; Maenaka K
J Biol Chem; 2009 Oct; 284(40):27327-35. PubMed ID: 19654330
[TBL] [Abstract][Full Text] [Related]
6. KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection.
Wang JM; Cheng YQ; Shi L; Ying RS; Wu XY; Li GY; Moorman JP; Yao ZQ
J Virol; 2013 Nov; 87(21):11626-36. PubMed ID: 23966413
[TBL] [Abstract][Full Text] [Related]
7. KLMab-1: An Anti-human KLRG1 Monoclonal Antibody for Immunocytochemistry.
Saito M; Suzuki H; Asano T; Tanaka T; Yoshikawa T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Oct; 41(5):279-284. PubMed ID: 36306514
[TBL] [Abstract][Full Text] [Related]
8. KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.
Assatova B; Willim R; Trevisani C; Haskett G; Kariya KM; Chopra K; Park SR; Tolstorukov MY; McCabe SM; Duffy J; Louissaint A; Huuhtanen J; Bhattacharya D; Mustjoki S; Koh MJ; Powers F; Morgan EA; Yang L; Pinckney B; Cotton MJ; Crabbe A; Ziemba JB; Brain I; Heavican-Foral TB; Iqbal J; Nemec R; Rider AB; Ford JG; Koh MJ; Scanlan N; Feith DJ; Loughran TP; Kim WS; Choi J; Roels J; Boehme L; Putteman T; Taghon T; Barnes JA; Johnson PC; Jacobsen ED; Greenberg SA; Weinstock DM; Jain S
Clin Cancer Res; 2024 Jun; 30(11):2514-2530. PubMed ID: 38252421
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of killer cell lectin-like receptor G1 expression on T cells.
Robbins SH; Terrizzi SC; Sydora BC; Mikayama T; Brossay L
J Immunol; 2003 Jun; 170(12):5876-85. PubMed ID: 12794113
[TBL] [Abstract][Full Text] [Related]
10. Expression of inhibitory "killer cell lectin-like receptor G1" identifies unique subpopulations of effector and memory CD8 T cells.
Beyersdorf NB; Ding X; Karp K; Hanke T
Eur J Immunol; 2001 Dec; 31(12):3443-52. PubMed ID: 11745363
[TBL] [Abstract][Full Text] [Related]
11. KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response.
Ager CR; Zhang M; Chaimowitz M; Bansal S; Tagore S; Obradovic A; Jugler C; Rogava M; Melms JC; McCann P; Spina C; Drake CG; Dallos MC; Izar B
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37657842
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of TIGIT and KLRG1 correlates with impaired CD56
Nie Y; Liu D; Yang W; Li Y; Zhang L; Cheng X; Chen R; Yuan B; Zhang G; Wang H
Virol J; 2022 Apr; 19(1):68. PubMed ID: 35413989
[TBL] [Abstract][Full Text] [Related]
13. KLRG1 restricts memory T cell antitumor immunity.
Li L; Wan S; Tao K; Wang G; Zhao E
Oncotarget; 2016 Sep; 7(38):61670-61678. PubMed ID: 27557510
[TBL] [Abstract][Full Text] [Related]
14. TGF-β downregulates KLRG1 expression in mouse and human CD8(+) T cells.
Schwartzkopff S; Woyciechowski S; Aichele U; Flecken T; Zhang N; Thimme R; Pircher H
Eur J Immunol; 2015 Aug; 45(8):2212-7. PubMed ID: 26014037
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic KLRG1 expressing lymphocytes invade portal tracts in primary biliary cholangitis.
Li Y; Li B; You Z; Zhang J; Wei Y; Li Y; Chen Y; Huang B; Wang Q; Miao Q; Peng Y; Fang J; Gershwin ME; Tang R; Greenberg SA; Ma X
J Autoimmun; 2019 Sep; 103():102293. PubMed ID: 31255417
[TBL] [Abstract][Full Text] [Related]
16. NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules.
Corral L; Hanke T; Vance RE; Cado D; Raulet DH
Eur J Immunol; 2000 Mar; 30(3):920-30. PubMed ID: 10741410
[TBL] [Abstract][Full Text] [Related]
17. An atypical KLRG1 in Nile tilapia involves in adaptive immunity as a potential marker for activated T lymphocytes.
Zhang Y; Li K; Li C; Liang W; Li K; Li J; Wei X; Yang J
Fish Shellfish Immunol; 2021 Jun; 113():51-60. PubMed ID: 33798718
[TBL] [Abstract][Full Text] [Related]
18. KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults.
Boer MC; van Meijgaarden KE; Goletti D; Vanini V; Prins C; Ottenhoff TH; Joosten SA
Tuberculosis (Edinb); 2016 Mar; 97():163-71. PubMed ID: 26750180
[TBL] [Abstract][Full Text] [Related]
19. Expression of KLRG1 and CD127 defines distinct CD8
Wu H; Tang X; Kim HJ; Jalali S; Pritchett JC; Villasboas JC; Novak AJ; Yang ZZ; Ansell SM
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34226281
[TBL] [Abstract][Full Text] [Related]
20. KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine
Novelli L; Barbati C; Capuano C; Recalchi S; Ceccarelli F; Vomero M; Alessandri C; Morrone S; Conti F
Lupus; 2023 Apr; 32(4):549-559. PubMed ID: 36876466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
